Trimedyne, Inc manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
Phone949-951-3800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$5.57 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date12/20/2019 (Estimated)
OptionableNot Optionable
Trimedyne (OTCMKTS:TMED) Frequently Asked Questions
What is Trimedyne's stock symbol?
Trimedyne trades on the OTCMKTS under the ticker symbol "TMED."
How were Trimedyne's earnings last quarter?
Trimedyne, Inc. (OTCMKTS:TMED) announced its quarterly earnings results on Tuesday, August, 27th. The technology company reported ($1.11) earnings per share for the quarter. The technology company earned $1.02 million during the quarter. View Trimedyne's Earnings History.
When is Trimedyne's next earnings date?
Has Trimedyne been receiving favorable news coverage?
News headlines about TMED stock have trended very negative this week, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Trimedyne earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Trimedyne.
Who are some of Trimedyne's key competitors?
What other stocks do shareholders of Trimedyne own?
Who are Trimedyne's key executives?
Trimedyne's management team includes the folowing people:
- Mr. Glenn D. Yeik, Interim Chairman, CEO & Pres (Age 51)
- Mr. Brian T. Kenney, VP of Global Sales & Marketing (Age 62)
How do I buy shares of Trimedyne?
Shares of TMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Trimedyne's stock price today?
One share of TMED stock can currently be purchased for approximately $4.56.
How big of a company is Trimedyne?
What is Trimedyne's official website?
How can I contact Trimedyne?
Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The technology company can be reached via phone at 949-951-3800.
MarketBeat Community Rating for Trimedyne (OTCMKTS TMED)
MarketBeat's community ratings are surveys of what our community members think about Trimedyne and other stocks. Vote "Outperform" if you believe TMED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMED will underperform the S&P 500 over the long term. You may vote once every thirty days.
